These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Severity of psychiatric symptoms as a predictor of benefits from psychotherapy: the Veterans Administration-Penn study. Woody GE; McLellan AT; Luborsky L; O'Brien CP; Blaine J; Fox S; Herman I; Beck AT Am J Psychiatry; 1984 Oct; 141(10):1172-7. PubMed ID: 6486249 [TBL] [Abstract][Full Text] [Related]
6. Psychotherapy in community methadone programs: a validation study. Woody GE; McLellan AT; Luborsky L; O'Brien CP Am J Psychiatry; 1995 Sep; 152(9):1302-8. PubMed ID: 7653685 [TBL] [Abstract][Full Text] [Related]
7. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care. King M; Sibbald B; Ward E; Bower P; Lloyd M; Gabbay M; Byford S Health Technol Assess; 2000; 4(19):1-83. PubMed ID: 11086269 [TBL] [Abstract][Full Text] [Related]
11. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model. King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792 [TBL] [Abstract][Full Text] [Related]
12. Psychoanalytically oriented psychotherapy of substance abuse (with observations on the Penn-VA Study). Okpaku SO Adv Alcohol Subst Abuse; 1986; 6(1):17-33. PubMed ID: 3812125 [TBL] [Abstract][Full Text] [Related]
13. Preventing recurrence of bipolar I mood episodes and hospitalizations: family psychotherapy plus pharmacotherapy versus pharmacotherapy alone. Solomon DA; Keitner GI; Ryan CE; Kelley J; Miller IW Bipolar Disord; 2008 Nov; 10(7):798-805. PubMed ID: 19032711 [TBL] [Abstract][Full Text] [Related]
14. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial. Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961 [TBL] [Abstract][Full Text] [Related]
15. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression. Kastelic A; Dubajic G; Strbad E Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534 [TBL] [Abstract][Full Text] [Related]
16. Controlled trial of prescribed heroin in the treatment of opioid addiction. March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F; J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749 [TBL] [Abstract][Full Text] [Related]
17. Psychotherapy/counseling for opiate addicts: strategies for use in different treatment settings. Rounsaville BJ; Kleber HD Int J Addict; 1985; 20(6-7):869-96. PubMed ID: 3908340 [TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users. Stein MD; Solomon DA; Herman DS; Anthony JL; Ramsey SE; Anderson BJ; Miller IW Arch Gen Psychiatry; 2004 Feb; 61(2):152-9. PubMed ID: 14757591 [TBL] [Abstract][Full Text] [Related]
19. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone. Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786 [TBL] [Abstract][Full Text] [Related]